{
BioLife Solutions, Inc.

Companies

}
001122334455554433221100
001122334455554433221100

healthcare consumables market poised for rapid growth driven by sustainability trends

The healthcare consumables market is projected to grow from $281.63 billion in 2023 to $466.65 billion by 2028, driven by rising hospital admissions, chronic disease prevalence, and the adoption of biodegradable products. Major players are focusing on eco-friendly innovations to enhance sustainability and meet increasing healthcare demands.
openPR.com
Nipro Corporation Medi-Plast Ltd. Fresenius Kabi AG Smith & Nephew plc Alcon Laboratories Inc. B. Braun Melsungen AG Zimmer Biomet Holdings, Inc. Invacare Corporation BioLife Solutions, Inc. Boston Scientific Corporation Johnson & Johnson Siemens Healthineers AG Abbott Laboratories Cardinal Health, Inc. GE HealthCare Technologies Inc. Coloplast A/S Philips Healthcare DexCom, Inc. Ortho-Clinical Diagnostics Inc. Terumo Corporation AngioDynamics, Inc. Becton Dickinson and Company (BD) Stryker Corporation Hollister Incorporated Hologic, Inc. 3M Company Brian Johnson Show more
Healthcare, Market Report
11:38 28.11.2024

global cell freezing media market poised for significant growth by 2033

The global cell freezing media market is projected to exceed $387.5 million by 2033, growing at a CAGR of 9.66% from 2023. North America is expected to dominate the market due to advanced healthcare infrastructure, while Asia-Pacific is anticipated to experience the fastest growth, driven by low costs and a focus on biologics manufacturing. Key players include Thermo Fisher Scientific and Merck, with innovations in cryopreservation techniques fueling market expansion.
Spherical Insights
United States Dollar Hemacare Company Capricorn Scientific GmbH Sartorius Aktiengesellschaft Cellular Applications, Inc. PromoCell GmbH Himedia Laboratories Ltd. Merck KGaA BioLife Solutions, Inc. Mediatech, Inc. Thermo Fisher Scientific Inc. Nippon Genetics AMSBIO USA QAT DEU ITA FRA MEX ARG AUS ZAF IND SAU RUS JPN KOR GBR BRA CAN ARE ESP CHN Show more
Healthcare, Market Report
04:05 19.11.2024

biotech hedge funds show mixed results as janus henderson leads the pack

The Janus Henderson Biotech Innovation Fund leads biopharma hedge funds with a 39.35% year-to-date gain, despite a less than 1% rise in September. Other funds like Casdin Capital and Averill Partners also performed well, while EcoR1 Capital faced significant losses, down 11.4% for the year.
Institutional Investor
Revolution Medicines, Inc. Amicus Therapeutics, Inc. Sarepta Therapeutics, Inc. BioLife Solutions, Inc. AbbVie Inc. Andy Acker Dan Lyons Joe Biden Show more
Finance & Economy, Market Report
17:35 23.10.2024
Trending
Subcategory
Startups & Entrepreneurship Corporate News Industry Trends Retail and Consumer Goods Supply Chain Management Global Trade Developments Stock Market Updates AI Applications Private Equity Deals Industry Mergers & Acquisitions AI Innovations Funding Rounds & Investments Fintech Startups Global Financial Events Energy Sector Developments Government Economic Policies CEO Changes Emerging Startups Corporate Social Responsibility Commodities
Countries:
USA CHN IND SAU ARE JPN GBR SGP VNM CAN BGD QAT KOR AUS MYS DEU IDN HKG NZL THA
Companies:
Apple Inc. Google Inc. Amazon.com, Inc. OpenAI ERC USD Tesmec S.p.A. Tesla, Inc. Microsoft Corporation Wise plc Mastercard Inc Walmart Inc. Mistral 1 Nippon Steel Corp Hollywood Bowl Group PLC NASDAQ Composite CCTV 50 CSR Medtronic plc Johnson & Johnson GE HealthCare Technologies Inc. McDonald's Corporation Toyota Motor Corp
Currencies:
United States Dollar Indian Rupee Chinese Yuan Euro British Pound Sterling United Arab Emirates Dirham Japanese Yen New Zealand Dollar Thai Baht Vietnamese Đồng Singapore Dollar Saudi Riyal Australian Dollar Omani Rial Bahraini Dinar Qatari Riyal Algerian Dinar
People:
Donald Trump Asmaa Naga Basma Bushnak Maha Taibah Hossam Ahmed Tasneem Islam Elon Musk Aman Gupta Joe Biden Afeef Zaman Hareb Rashed Rajneel Kumar Mark Carney Howard Lutnick Yongqiang He Ursula von der Leyen Ahmed al-Sharaa Enoch Fung Liad Agmon Dani Aronovitz

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.